TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million October 31, 1980
